The translational space for epilepsy presents an arid landscape. The Epilepsy Therapy Projectis trying to reverse the status quo and thinks it can help bridge the translational gap with a combination of grants, investments, guidance and matchmaking for companies and academics working on epilepsy.
According to ETP president Joyce Cramer, the reason for the lack of new drugs and devices for epilepsy is the perception "that it's all taken care of-it's an understandable misconception given there are 14 medications available."
However, the list of unmet needs in the indication is long."For 30%-40% of the epilepsy population, seizures are uncontrolled, and that hasn't changed over the last decades," said ETP chairman and cofounder Warren Lammert, who has